Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TRAIL and ceramide.

Yong J Lee1, Andrew A Amoscato

  • 1Department of Surgery and Pharmacology, University of Pittsburgh, Pennsylvania 15213, USA.

Vitamins and Hormones
|April 28, 2004
PubMed
Summary

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in cancer cells. This review explores how ceramide signaling pathways interact with TRAIL to regulate cell death, enhancing anti-cancer effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumoricidal efficacy of DZ-1 dye conjugated to dihydroartemisinin in patient-derived colorectal liver metastasis tumoroids.

Molecular therapy. Oncology·2026
Same author

Linker-dependent variations in the tumoricidal activity of DZ-1-dihydroartemisinin conjugate formats.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

DZ-1-artesunate conjugate induces mitochondria-mediated, reactive oxygen species-dependent apoptosis in colorectal cancer tumoroids.

Frontiers in pharmacology·2026
Same author

Tumoricidal Efficacy of Artesunate-Eluting Microsphere-Based Multimodal Therapy in Patient-Derived Colorectal Tumoroids.

Biomaterials research·2026
Same author

SRC at the crossroads of KRAS inhibitor resistance: Mechanisms and therapeutic opportunities.

Cancer letters·2025
Same author

DZ-1-Artesunate Induces Apoptosis Via a Bid-, Bax-, and Bak-Independent Caspase-3 Activation Pathway.

Journal of oncology research and therapy·2025

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis in cancer cells.
  • Differential sensitivity to TRAIL is mediated by death receptors, decoy receptors, and death inhibitors.
  • Genotoxic agents can enhance TRAIL-induced cytotoxicity by modulating DR5 expression and FLIP levels.

Purpose of the Study:

  • To review the interaction between TRAIL and ceramide signaling pathways.
  • To discuss the role of ceramide in regulating TRAIL-induced apoptosis.
  • To explore the potential of targeting these pathways for cancer therapy.

Main Methods:

  • Literature review of studies on TRAIL, ceramide, and apoptosis.
  • Analysis of molecular mechanisms underlying TRAIL sensitivity and resistance.
  • Integration of findings on ceramide metabolism and its role in stress response.

Main Results:

  • Ceramide plays a crucial role in regulating cellular responses to stress.
  • Increases in intracellular ceramide levels can modulate apoptosis through various signaling molecules.
  • The interplay between TRAIL and ceramide pathways offers a potential strategy for enhancing anti-cancer therapies.

Conclusions:

  • Ceramide signaling is intricately linked with TRAIL-mediated apoptosis.
  • Understanding this interaction can lead to novel therapeutic approaches for cancer treatment.
  • Targeting ceramide pathways may overcome TRAIL resistance in tumors.

Related Experiment Videos